PT  - JOURNAL ARTICLE
AU  - El Khoury, Christelle
AU  - Albiac, Laura Crespo
AU  - O’Dwyer, Marie Claire
AU  - Haro, Elizabeth
AU  - Alves, Martha
AU  - Jimbo, Masahito
AU  - Harper, Diane
AU  - Gorin, Sherri Sheinfeld
AU  - Meixner, Kaitlin
AU  - Capizzano, Juana Nicoll
AU  - Salada, Cullen
TI  - Patient-centered home cancer screening attitudes during SARS-CoV-2 pandemic
AID  - 10.1370/afm.20.s1.2639
DP  - 2022 Apr 01
TA  - The Annals of Family Medicine
PG  - 2639
VI  - 20
IP  - Supplement 1
4099  - http://www.annfammed.org/content/20/Supplement_1/2639.short
4100  - http://www.annfammed.org/content/20/Supplement_1/2639.full
SO  - Ann Fam Med2022 Apr 01; 20
AB  - COVID-19 has caused disruptions in health care, in particular cancer screenings. The primary aim of our work was to evaluate the degree to which populations were accepting of home-based screenings for colorectal cancer (CRC) and cervical cancer (primary HPV testing). Three groups of adults having distinct health burdens which may affect acceptance of home-based cancer screening were identified through outpatient electronic medical records as follows as either having survived a COVID hospitalization, having been positive for non-COVID respiratory illness or having type 2 diabetes. 132 respondents (58% female) completed an online survey with hypothetical cases about their acceptance of home-based CRC or cervical cancer screening. Among females, urine and vaginal screening for primary HPV testing was acceptable to 64% and 59%, respectively. Among both males and females, CRC home screening with fecal immunochemical test (FIT) or Cologuard ® was acceptable to 60% of the respondents. When adjusting for education, women with a positive attitude toward home-based urine /vaginal screening were 49 times and 23 times more likely to have a positive attitude toward CRC screening (aOR=48.7 (95% CI: 7.1, 337) and aOR=23.2 (95% CI: 3.8, 142), respectively). This report indicates that home-based cancer screens for CRC and primary HPV testing are acceptable to men and women and may allow for greater compliance with screening in the future.